Joel Gore to Administration, Oral
This is a "connection" page, showing publications Joel Gore has written about Administration, Oral.
Connection Strength
0.100
-
Makam RCP, Hoaglin DC, McManus DD, Wang V, Gore JM, Spencer FA, Pradhan R, Tran H, Yu H, Goldberg RJ. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis. PLoS One. 2018; 13(5):e0197583.
Score: 0.035
-
Park KL, Goldberg RJ, Anderson FA, L?pez-Send?n J, Montalescot G, Brieger D, Eagle KA, Wyman A, Gore JM. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE). Am J Med. 2014 Jun; 127(6):503-11.
Score: 0.026
-
Alonso A, Gore JM, Awad HH, Quill AL, Montalescot G, van de Werf F, Gulba DC, Fox KA, Eagle KA, Granger CB, Wyman A, Steg PG. Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry. Eur Heart J Acute Cardiovasc Care. 2013 Sep; 2(3):280-91.
Score: 0.025
-
Mohapatra R, Tran M, Gore JM, Spencer FA. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era... Am Heart J. 2005 Jul; 150(1):19-26.
Score: 0.014